Vita 34 AG

Banking cord blood, stem cell research

Vita 34 AG was founded in 1997 by Eberhard F. Lampeter and Dr. med. Uwe Marx as first company in Europe producing umbilial cord preparations. The name is a composite of VITA (=life) and 34 referring to the surface molecule CD34, a transmembrane glycoprotein constitutively expressed on endothelial cells and on haematopoietic stem cells. In July 2004, Philadelphia based CorCell, Inc. and Germany- based VITA 34 merged to form VITA 34 INTERNATIONAL AG, a new holding company headquartered in Leipzig, Germany. CorCell and VITA 34 will continue to operate under their established brand names in their respective markets. Both companies are both wholly owned subsidiaries of VITA 34 INTERNATIONAL AG.

Eberhard F. Lampeter, Dr., CEO & Founder
Peter Boehnert, CFO
Oliver Papavlassopoulos, CMO

Richard J. Neeson, Chairman
Hubertus Leonhardt, Assistant Chairman
Dr. med Uwe Marx
Joseph H. Jacovini
Steven I. Udvarhelyi
Prof. Dr. med. Ch. Hohbach

Prof. Dr. med. Dr. h.c. Wolfgang Holzgreve
Prof. Dr. med. Eckart Wunder
Prof. Dr. med. Augustinus Bader

Deutscher Platz 5a
04103 Leipzig
Germany
Phone: +49-341-48792-0
Fax: +49-341-48792-20

Cord blood is processed in a modern, state-of-the-art laboratory with class B clean rooms in accordance with the German Medicines Act and subsequently stored.

The following section contains a selection of the company’s most relevant patents. For comprehensive patent information please refer to the espacenet databases.